UBS Group’s ESGEN Acquisition Corporation Unit ESACU Stock Holding History

UBS Group’s Portfolio ESACU Stock Details ESACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3	Closed	-$33	–	10264
2023 Q3	$33	Sell	3 -1	-25%	-$11	﹤0.01%	9068
2023 Q2	$44	Buy	+4	New	+$42	﹤0.01%	8618
2023 Q1	–	Sell	-112	Closed	-$1.15K	–	10860
2022 Q4	$1.15K	Hold	112	–	–	﹤0.01%	9939
2022 Q3	$1K	Hold	112	–	–	﹤0.01%	10122
2022 Q2	$1K	Buy	+112	New	+$1.13K	﹤0.01%	10054

Other funds holding ESACU

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group's ESACU Position: Q4 2023 in Review

UBS Group sold out of ESGEN Acquisition Corporation Unit (ESACU) in Q4 2023, closing a stake of 3 shares — an estimated $33 sold.

UBS Group first reported a position in ESACU in Q2 2022 and held it in 5 quarters. The position peaked at $1.15K in Q4 2022. 2 funds tracked by Wall St. Rank hold ESACU as of Q4 2023.

UBS Group reported no remaining ESGEN Acquisition Corporation Unit position as of Q4 2023 after selling out during the quarter.
UBS Group sold 3 ESGEN Acquisition Corporation Unit shares in Q4 2023, an estimated $33.
UBS Group first reported a position in ESGEN Acquisition Corporation Unit in Q2 2022 and held it in 5 quarters.
UBS Group's ESGEN Acquisition Corporation Unit position peaked at $1.15K in Q4 2022.
2 funds tracked by Wall St. Rank held ESGEN Acquisition Corporation Unit as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.